Cargando…

Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year

Healthcare workers (HCWs) are playing a vital role in the current SARS-CoV-2 pandemic. This study investigated how infection spreads within three local hospitals and an associated fire brigade in Germany by testing employees for the presence of SARS-CoV-2 IgG antibodies over one year. The three obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Hildebrandt, Anke, Hökelekli, Oktay, Uflacker, Lutz, Rudolf, Henrik, Paulussen, Michael, Gatermann, Sören G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878380/
https://www.ncbi.nlm.nih.gov/pubmed/35206589
http://dx.doi.org/10.3390/ijerph19042402
_version_ 1784658647272390656
author Hildebrandt, Anke
Hökelekli, Oktay
Uflacker, Lutz
Rudolf, Henrik
Paulussen, Michael
Gatermann, Sören G.
author_facet Hildebrandt, Anke
Hökelekli, Oktay
Uflacker, Lutz
Rudolf, Henrik
Paulussen, Michael
Gatermann, Sören G.
author_sort Hildebrandt, Anke
collection PubMed
description Healthcare workers (HCWs) are playing a vital role in the current SARS-CoV-2 pandemic. This study investigated how infection spreads within three local hospitals and an associated fire brigade in Germany by testing employees for the presence of SARS-CoV-2 IgG antibodies over one year. The three observational periods corresponded to the initial three pandemic waves: first wave: June–September 2020, second wave: October 2020–January 2021, and third wave: February–June 2021. We analysed 3285 serum samples of 1842 employees, which represents 65.7% of all employees. Altogether, 13.2% employees were seropositive: 194/1411 HCWs (13.7%) and 49/431 non-HCWs (11.4%) with a clear increase of seroprevalence from the first (1.1%) to the second (13.2%) and third (29.3%) pandemic wave. HCWs presumably had an additional occupational risk for infection in the second and third wave due to an increase of infection pressure with more COVID-19 patients treated, showing possible weak points in the recommended infection prevention strategy.
format Online
Article
Text
id pubmed-8878380
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88783802022-02-26 Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year Hildebrandt, Anke Hökelekli, Oktay Uflacker, Lutz Rudolf, Henrik Paulussen, Michael Gatermann, Sören G. Int J Environ Res Public Health Article Healthcare workers (HCWs) are playing a vital role in the current SARS-CoV-2 pandemic. This study investigated how infection spreads within three local hospitals and an associated fire brigade in Germany by testing employees for the presence of SARS-CoV-2 IgG antibodies over one year. The three observational periods corresponded to the initial three pandemic waves: first wave: June–September 2020, second wave: October 2020–January 2021, and third wave: February–June 2021. We analysed 3285 serum samples of 1842 employees, which represents 65.7% of all employees. Altogether, 13.2% employees were seropositive: 194/1411 HCWs (13.7%) and 49/431 non-HCWs (11.4%) with a clear increase of seroprevalence from the first (1.1%) to the second (13.2%) and third (29.3%) pandemic wave. HCWs presumably had an additional occupational risk for infection in the second and third wave due to an increase of infection pressure with more COVID-19 patients treated, showing possible weak points in the recommended infection prevention strategy. MDPI 2022-02-19 /pmc/articles/PMC8878380/ /pubmed/35206589 http://dx.doi.org/10.3390/ijerph19042402 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hildebrandt, Anke
Hökelekli, Oktay
Uflacker, Lutz
Rudolf, Henrik
Paulussen, Michael
Gatermann, Sören G.
Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year
title Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year
title_full Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year
title_fullStr Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year
title_full_unstemmed Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year
title_short Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year
title_sort seroprevalence of sars-cov-2 antibodies in employees of three hospitals of a secondary care hospital network in germany and an associated fire brigade: results of a repeated cross-sectional surveillance study over 1 year
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878380/
https://www.ncbi.nlm.nih.gov/pubmed/35206589
http://dx.doi.org/10.3390/ijerph19042402
work_keys_str_mv AT hildebrandtanke seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year
AT hokeleklioktay seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year
AT uflackerlutz seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year
AT rudolfhenrik seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year
AT paulussenmichael seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year
AT gatermannsoreng seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year